Literature DB >> 19635916

Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.

Roberto Burioni1, Filippo Canducci, Diego Saita, Mario Perotti, Nicasio Mancini, Donata De Marco, Nicola Clementi, Alaide Chieffo, Maurizio Denaro, Domenico Cianflone, Angelo A Manfredi, Antonio Colombo, Attilio Maseri, Massimo Clementi.   

Abstract

Recent data indicated that adaptive immunity is involved in the process of atherogenesis. Oligoclonal recruitment of T lymphocytes has been described in coronary plaques of patients with acute coronary syndrome. However, the nature of immune response remains to be determined. In the present study, we examined the Ab response in six coronary plaques obtained by endoluminal directional atherectomy. The IgG1/kappa-coding gene repertoires of B lymphocytes present in circulating blood and in coronary plaques were cloned and analyzed. In all of the six plaques, we observed 1) a skewed usage of heavy and light IgG1/kappa Ab-coding genes, 2) an oligoclonal distribution of V(K), J(K), and V(H), D(H), and J(H) genes with overrepresentation of some rarely used IgG genes, and 3) the unequivocal signs of Ag-driven clonal expansion and evolution of B cells. The data document for the first time the presence of a local Ag-driven clonal evolution of B cells in human atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635916     DOI: 10.4049/jimmunol.0901076

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Lymphocytes and the adventitial immune response in atherosclerosis.

Authors:  Kirsti A Campbell; Michael J Lipinski; Amanda C Doran; Marcus D Skaflen; Valentin Fuster; Coleen A McNamara
Journal:  Circ Res       Date:  2012-03-16       Impact factor: 17.367

2.  Ancestral resurrection of anthropoid estrogen receptor β demonstrates functional consequences of positive selection.

Authors:  Amy Weckle; Michael R McGowen; Jun Xing; Caoyi Chen; Kirstin N Sterner; Zhuo-Cheng Hou; Roberto Romero; Derek E Wildman
Journal:  Mol Phylogenet Evol       Date:  2017-09-13       Impact factor: 4.286

Review 3.  The role of T and B cells in human atherosclerosis and atherothrombosis.

Authors:  E Ammirati; F Moroni; M Magnoni; P G Camici
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

Review 4.  Opportunities for an atherosclerosis vaccine: From mice to humans.

Authors:  Payel Roy; Amal J Ali; Kouji Kobiyama; Yanal Ghosheh; Klaus Ley
Journal:  Vaccine       Date:  2020-01-19       Impact factor: 3.641

Review 5.  Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.

Authors:  Andrew P Sage; Ziad Mallat
Journal:  Br J Pharmacol       Date:  2017-02-01       Impact factor: 8.739

6.  Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients.

Authors:  Filippo Canducci; Diego Saita; Chiara Foglieni; Maria Rosaria Piscopiello; Roberto Chiesa; Antonio Colombo; Domenico Cianflone; Attilio Maseri; Massimo Clementi; Roberto Burioni
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

Review 7.  HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role.

Authors:  Giuseppe Sautto; Nicasio Mancini; Laura Solforosi; Roberta A Diotti; Massimo Clementi; Roberto Burioni
Journal:  Clin Dev Immunol       Date:  2012-05-29

Review 8.  Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.

Authors:  Adriana Albini; Giuseppina Pennesi; Francesco Donatelli; Rosaria Cammarota; Silvio De Flora; Douglas M Noonan
Journal:  J Natl Cancer Inst       Date:  2009-12-10       Impact factor: 13.506

Review 9.  Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis.

Authors:  Justine Deroissart; Florentina Porsch; Thomas Koller; Christoph J Binder
Journal:  Handb Exp Pharmacol       Date:  2022

Review 10.  Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).

Authors:  Giuseppe Sautto; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-08       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.